Literature DB >> 29802435

Treatment planning for spinal radiosurgery : A competitive multiplatform benchmark challenge.

Christos Moustakis1, Mark K H Chan2, Jinkoo Kim3, Joakim Nilsson4, Alanah Bergman5, Tewfik J Bichay6,7, Isabel Palazon Cano8, Savino Cilla9, Francesco Deodato10, Raffaela Doro11, Jürgen Dunst2,12, Hans Theodor Eich13, Pierre Fau14,15, Ming Fong16, Uwe Haverkamp13, Simon Heinze17, Guido Hildebrandt18, Detlef Imhoff19, Erik de Klerck20, Janett Köhn19, Ulrike Lambrecht21, Britta Loutfi-Krauss19, Fatemeh Ebrahimi13, Laura Masi11, Alan H Mayville6, Ante Mestrovic5, Maaike Milder20, Alessio G Morganti22, Dirk Rades23, Ulla Ramm19, Claus Rödel19, Frank-Andre Siebert2, Wilhelm den Toom20, Lei Wang24, Stefan Wurster25,26, Achim Schweikard27, Scott G Soltys24, Samuel Ryu3, Oliver Blanck2,25.   

Abstract

PURPOSE: To investigate the quality of treatment plans of spinal radiosurgery derived from different planning and delivery systems. The comparisons include robotic delivery and intensity modulated arc therapy (IMAT) approaches. Multiple centers with equal systems were used to reduce a bias based on individual's planning abilities. The study used a series of three complex spine lesions to maximize the difference in plan quality among the various approaches.
METHODS: Internationally recognized experts in the field of treatment planning and spinal radiosurgery from 12 centers with various treatment planning systems participated. For a complex spinal lesion, the results were compared against a previously published benchmark plan derived for CyberKnife radiosurgery (CKRS) using circular cones only. For two additional cases, one with multiple small lesions infiltrating three vertebrae and a single vertebra lesion treated with integrated boost, the results were compared against a benchmark plan generated using a best practice guideline for CKRS. All plans were rated based on a previously established ranking system.
RESULTS: All 12 centers could reach equality (n = 4) or outperform (n = 8) the benchmark plan. For the multiple lesions and the single vertebra lesion plan only 5 and 3 of the 12 centers, respectively, reached equality or outperformed the best practice benchmark plan. However, the absolute differences in target and critical structure dosimetry were small and strongly planner-dependent rather than system-dependent. Overall, gantry-based IMAT with simple planning techniques (two coplanar arcs) produced faster treatments and significantly outperformed static gantry intensity modulated radiation therapy (IMRT) and multileaf collimator (MLC) or non-MLC CKRS treatment plan quality regardless of the system (mean rank out of 4 was 1.2 vs. 3.1, p = 0.002).
CONCLUSIONS: High plan quality for complex spinal radiosurgery was achieved among all systems and all participating centers in this planning challenge. This study concludes that simple IMAT techniques can generate significantly better plan quality compared to previous established CKRS benchmarks.

Entities:  

Keywords:  Benchmark study; Multicenter; Multiplatform; Spinal radiosurgery; Stereotactic body radiation therapy; Treatment planning challenge

Mesh:

Year:  2018        PMID: 29802435     DOI: 10.1007/s00066-018-1314-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  34 in total

1.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

2.  Feasibility study of patient positioning verification in electron beam radiotherapy with an electronic portal imaging device (EPID).

Authors:  U Ramm; J Köhn; R Rodriguez Dominguez; J Licher; N Koch; E Kara; C Scherf; C Rödel; C Weiß
Journal:  Phys Med       Date:  2013-07-11       Impact factor: 2.685

3.  An analysis of knowledge-based planning for stereotactic body radiation therapy of the spine.

Authors:  Joseph J Foy; Robin Marsh; Randall K Ten Haken; Kelly C Younge; Matthew Schipper; Yilun Sun; Dawn Owen; Martha M Matuszak
Journal:  Pract Radiat Oncol       Date:  2017-03-02

4.  CyberArc: a non-coplanar-arc optimization algorithm for CyberKnife.

Authors:  Vasant Kearney; Joey P Cheung; Christopher McGuinness; Timothy D Solberg
Journal:  Phys Med Biol       Date:  2017-06-26       Impact factor: 3.609

5.  Comparison of Ray Tracing and Monte Carlo Calculation Algorithms for Thoracic Spine Lesions Treated With CyberKnife-Based Stereotactic Body Radiation Therapy.

Authors:  Christian C Okoye; Ravi B Patel; Shaakir Hasan; Tarun Podder; Anton Khouri; Jeffrey Fabien; Yuxia Zhang; Donald Dobbins; Jason W Sohn; Jiankui Yuan; Min Yao; Mitchell Machtay; Andrew E Sloan; Jonathan Miller; Simon S Lo
Journal:  Technol Cancer Res Treat       Date:  2015-01-28

6.  A Monte Carlo approach to validation of FFF VMAT treatment plans for the TrueBeam linac.

Authors:  Ermias Gete; Cheryl Duzenli; Marie-Pierre Milette; Ante Mestrovic; Derek Hyde; Alanah Mary Bergman; Tony Teke
Journal:  Med Phys       Date:  2013-02       Impact factor: 4.071

7.  Characteristics and performance of the first commercial multileaf collimator for a robotic radiosurgery system.

Authors:  Christoph Fürweger; Paulette Prins; Harun Coskan; Ben J M Heijmen
Journal:  Med Phys       Date:  2016-05       Impact factor: 4.071

8.  Patient motion and targeting accuracy in robotic spinal radiosurgery: 260 single-fraction fiducial-free cases.

Authors:  Christoph Fürweger; Christian Drexler; Markus Kufeld; Alexander Muacevic; Berndt Wowra; Alexander Schlaefer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-13       Impact factor: 7.038

Review 9.  Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy.

Authors:  Jimm Grimm; Tamara LaCouture; Raymond Croce; Inhwan Yeo; Yunping Zhu; Jinyu Xue
Journal:  J Appl Clin Med Phys       Date:  2011-02-08       Impact factor: 2.243

10.  CyberKnife robotic spinal radiosurgery in prone position: dosimetric advantage due to posterior radiation access?

Authors:  Christoph Fürweger; Christian Drexler; Alexander Muacevic; Berndt Wowra; Erik C de Klerck; Mischa S Hoogeman
Journal:  J Appl Clin Med Phys       Date:  2014-07-08       Impact factor: 2.102

View more
  10 in total

1.  SBRT planning for spinal metastasis: indications from a large multicentric study.

Authors:  Marco Esposito; Laura Masi; Margherita Zani; Raffaela Doro; David Fedele; Cristina Garibaldi; Stefania Clemente; Christian Fiandra; Francesca Romana Giglioli; Carmelo Marino; Laura Orsingher; Serenella Russo; Michele Stasi; Lidia Strigari; Elena Villaggi; Pietro Mancosu
Journal:  Strahlenther Onkol       Date:  2018-10-23       Impact factor: 3.621

2.  Stereotactic body radiotherapy for ventricular tachycardia (cardiac radiosurgery) : First-in-patient treatment in Germany.

Authors:  David Krug; Oliver Blanck; Thomas Demming; Matthias Dottermusch; Karoline Koch; Markus Hirt; Laura Kotzott; Adrian Zaman; Lina Eidinger; Frank-Andre Siebert; Jürgen Dunst; Hendrik Bonnemeier
Journal:  Strahlenther Onkol       Date:  2019-10-31       Impact factor: 3.621

3.  Tumor-dose-rate variations during robotic radiosurgery of oligo and multiple brain metastases.

Authors:  Maria-Lisa Wilhelm; Mark K H Chan; Benedikt Abel; Florian Cremers; Frank-Andre Siebert; Stefan Wurster; David Krug; Robert Wolff; Jürgen Dunst; Guido Hildebrandt; Achim Schweikard; Dirk Rades; Floris Ernst; Oliver Blanck
Journal:  Strahlenther Onkol       Date:  2020-06-25       Impact factor: 3.621

4.  A dosimetric analysis of a spine SBRT specific treatment planning system.

Authors:  Daniel L Saenz; Richard Crownover; Sotirios Stathakis; Niko Papanikolaou
Journal:  J Appl Clin Med Phys       Date:  2018-11-20       Impact factor: 2.102

5.  Automatic image segmentation based on synthetic tissue model for delineating organs at risk in spinal metastasis treatment planning.

Authors:  Olaf Wittenstein; Patrick Hiepe; Lars Henrik Sowa; Elias Karsten; Iris Fandrich; Juergen Dunst
Journal:  Strahlenther Onkol       Date:  2019-04-29       Impact factor: 3.621

6.  A Special Report on 2019 International Planning Competition and a Comprehensive Analysis of Its Results.

Authors:  Jiayun Chen; Jianrong Dai; Ahmad Nobah; Sen Bai; Nan Bi; Youqun Lai; Minghui Li; Yuan Tian; Xuetao Wang; Qi Fu; Bin Liang; Tao Zhang; Wenlong Xia; Yuan Xu; Wenting Ren; Xuena Yan; Ji Zhu; Deqi Chen; Jiming Yang
Journal:  Front Oncol       Date:  2020-12-04       Impact factor: 6.244

7.  Personalized Automation of Treatment Planning for Linac-Based Stereotactic Body Radiotherapy of Spine Cancer.

Authors:  Savino Cilla; Francesco Cellini; Carmela Romano; Gabriella Macchia; Donato Pezzulla; Pietro Viola; Milly Buwenge; Luca Indovina; Vincenzo Valentini; Alessio G Morganti; Francesco Deodato
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

8.  Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis.

Authors:  Conti Alfredo; Senger Carolin; Acker Güliz; Kluge Anne; Pontoriero Antonio; Cacciola Alberto; Pergolizzi Stefano; Germanò Antonino; Badakhshi Harun; Kufeld Markus; Meinert Franziska; Nguyen Phuong; Loebel Franziska; Vajkoczy Peter; Budach Volker; Kaul David
Journal:  Radiat Oncol       Date:  2019-11-12       Impact factor: 3.481

9.  Full automation of spinal stereotactic radiosurgery and stereotactic body radiation therapy treatment planning using Varian Eclipse scripting.

Authors:  Jose R Teruel; Martha Malin; Elisa K Liu; Allison McCarthy; Kenneth Hu; Bejamin T Cooper; Erik P Sulman; Joshua S Silverman; David Barbee
Journal:  J Appl Clin Med Phys       Date:  2020-09-23       Impact factor: 2.102

10.  Head and neck radiotherapy on the MR linac: a multicenter planning challenge amongst MRIdian platform users.

Authors:  Madalyne Chamberlain; Jerome Krayenbuehl; Janita E van Timmeren; Lotte Wilke; Nicolaus Andratschke; Helena Garcia Schüler; Stephanie Tanadini-Lang; Matthias Guckenberger; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2021-04-23       Impact factor: 3.621

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.